Pancreatic cancer
Conditions
Interventions
None listed
Sponsors
Department of hepato-biliary-pancreatic surgery, Okayama University Graduate School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.In the case where the primary lesion is confirmed to be pancreatic cancer by histology, cytology, or imaging examination 2.Initial treatment case 3.Performance status (ECOG) is 0 or 1 4.Cases in which consent for the participation in this study was obtained by the signature of the person before registration 5.Equal to or more than 20 years old 6.Gender:Regardless 7.Admission or outpatient:Regardless
Exclusion criteria
Exclusion criteria: 1.Cases without consent for the participation in this study 2.Cases with pregnancy or possibility of pregnancy 3.Cases with pulmonary dysfunction(arterial PaO2<=70mmHg) 4.Cases with cardiac dysfunction(New York Heart Association classification>=Class 3) 5.Cases with liver dysfunction(Child Pugh C) 6.Cases with renal dysfunction(patients with hemodialysis) 7.Cases with active infection 8.History of neurologically or psychologically significant disease, and cases with complications 9.Patients with best supportive care(BSC) 10.Patients whom principal investigator judged inappropriate for subjects of the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| relationship between the transition of CA19-9 and clinical outcome | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall survival Progression free survival Recurrence free survival Histopathological response rate for chemotherapy Complications or adverse effects due to chemotherapy | — |
Countries
Japan
Contacts
Public ContactKokichi Miyamoto
Okayama University Graduate School of Medicine Department of hepato-biliary-pancreatic surgery
Outcome results
None listed